
As the World Health Assembly Convenes, Let’s Elevate Use of Economic Evidence on the UHC Agenda
Since Monday, leading health officials from around the world have been meeting in Geneva, Switzerland for the 72nd World Health Assembly.
Ideas to Action:
Independent research for global prosperity
With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
CGD works to reduce global poverty and improve lives through innovative economic research that drives better policy and practice by the world’s top decision makers.
CGD experts offer ideas and analysis to improve international development policy. Also check out our Global Health blog and US Development Policy blog.
Since Monday, leading health officials from around the world have been meeting in Geneva, Switzerland for the 72nd World Health Assembly.
In March, our team at the Center for Global Development and Office of Health Economics posted a consultation draft of a policy proposal for a Market-Driven, Value-Based Advanced Commitment (MVAC). The MVAC is a new mechanism that puts middle-income country governments in the driver’s seat to accelerate R&D for diseases that affect the world’s poor—specifically, the 10 million men, women, and children who develop tuberculosis (TB) disease each year and desperately need better therapies.
Innovation is a critical tool in the global fight against disease—especially for tuberculosis (TB), an infectious disease that primarily affects the poor and vulnerable and ranks among the top 10 causes of death in the world.
CGD experts explain how the BRICS—home to 40 percent of all cases last year—could provide much-needed leadership on the global TB agenda.
We finally have some clarity on PEPFAR’s new “acceleration” strategy toward epidemic control: a lot more allocated to a few countries, and a lot less for others.
Each of the G20 summits of the past seven years has suffered in comparison with the London and Pittsburgh Summits of 2009, when the imperative of crisis response motivated leaders, finance ministers, and central bankers to coordinate effectively with each other. Subsequent summits have lacked the same sense of urgency and have failed to deliver any kind of agenda that can be pinpointed as clearly as “saving the global economy.” This week’s summit in Hamburg, Germany promises more of the same, with the real possibility that the G20’s stock could fall even further at the hands of a non-cooperative US delegation.
In its opening days, the Women Deliver conference in Copenhagen has bestowed praise and congratulations on the women’s rights advocacy community writ large—and appropriately so. Some of the panelists have risked their lives and livelihoods to create a better world for women and girls; recognition of their accomplishments is truly the least we can do. Many others have dedicated their distinguished careers to this cause, trailblazing the path for later generations. But there’s a lot we still have to accomplish.
Five thousand researchers, practitioners, advocates and others are descending on Copenhagen for Women Deliver, the largest conference focused on the health, rights, and well-being of women and girls. Much of what will be discussed aligns with CGD’s own work through our global health policy and gender and development programs, so we’re pleased to be attending and below, we’re pleased to share with you a few of the conference areas where we can add our voice.
While the numbers coming out of side events at Addis were hardly worth the single shake of a string-free pom-pom, and the launch of a Global Partnership for Sustainable Development Data raised a lot of questions, there were some bright spots in the US commitments to that partnership.
Commentary Menu